Free Trial
→ Read this warning immediately (From Porter & Company) (Ad)tc pixel Free AVAH Stock Alerts

Aveanna Healthcare (AVAH) Competitors

Aveanna Healthcare logo
$7.09 +0.09 (+1.29%)
Closing price 06/12/2026 04:00 PM Eastern
Extended Trading
$7.05 -0.04 (-0.51%)
As of 06/12/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

AVAH vs. PACS, CAI, BLLN, SHC, and RDNT

Should you buy Aveanna Healthcare stock or one of its competitors? MarketBeat compares Aveanna Healthcare with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Aveanna Healthcare include PACS Group (PACS), Caris Life Sciences (CAI), Billiontoone (BLLN), Sotera Health (SHC), and RadNet (RDNT). These companies are all part of the "healthcare" industry.

How does Aveanna Healthcare compare to PACS Group?

Aveanna Healthcare (NASDAQ:AVAH) and PACS Group (NYSE:PACS) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, risk, earnings, media sentiment, dividends and valuation.

Aveanna Healthcare has higher earnings, but lower revenue than PACS Group. Aveanna Healthcare is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aveanna Healthcare$2.43B0.63$225.03M$1.186.01
PACS Group$5.29B1.09$191.54M$1.5623.33

Aveanna Healthcare currently has a consensus target price of $10.50, indicating a potential upside of 48.10%. PACS Group has a consensus target price of $48.00, indicating a potential upside of 31.89%. Given Aveanna Healthcare's higher probable upside, equities analysts plainly believe Aveanna Healthcare is more favorable than PACS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aveanna Healthcare
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.67
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

Aveanna Healthcare has a net margin of 10.37% compared to PACS Group's net margin of 4.49%. Aveanna Healthcare's return on equity of 124.68% beat PACS Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Aveanna Healthcare10.37% 124.68% 7.07%
PACS Group 4.49%26.47%4.36%

88.0% of Aveanna Healthcare shares are held by institutional investors. 5.3% of Aveanna Healthcare shares are held by company insiders. Comparatively, 70.1% of PACS Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Aveanna Healthcare had 3 more articles in the media than PACS Group. MarketBeat recorded 4 mentions for Aveanna Healthcare and 1 mentions for PACS Group. Aveanna Healthcare's average media sentiment score of 0.59 beat PACS Group's score of -0.35 indicating that Aveanna Healthcare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aveanna Healthcare
0 Very Positive mention(s)
3 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
PACS Group
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Aveanna Healthcare beats PACS Group on 10 of the 16 factors compared between the two stocks.

How does Aveanna Healthcare compare to Caris Life Sciences?

Caris Life Sciences (NASDAQ:CAI) and Aveanna Healthcare (NASDAQ:AVAH) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, valuation, institutional ownership, profitability, risk and analyst recommendations.

Aveanna Healthcare has higher revenue and earnings than Caris Life Sciences. Caris Life Sciences is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Caris Life Sciences$812.03M6.26-$68.09M-$7.61N/A
Aveanna Healthcare$2.43B0.63$225.03M$1.186.01

Aveanna Healthcare has a net margin of 10.37% compared to Caris Life Sciences' net margin of 3.75%. Aveanna Healthcare's return on equity of 124.68% beat Caris Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Caris Life Sciences3.75% 98.28% 48.87%
Aveanna Healthcare 10.37%124.68%7.07%

88.0% of Aveanna Healthcare shares are held by institutional investors. 50.0% of Caris Life Sciences shares are held by insiders. Comparatively, 5.3% of Aveanna Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Caris Life Sciences had 3 more articles in the media than Aveanna Healthcare. MarketBeat recorded 7 mentions for Caris Life Sciences and 4 mentions for Aveanna Healthcare. Caris Life Sciences' average media sentiment score of 0.73 beat Aveanna Healthcare's score of 0.59 indicating that Caris Life Sciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Caris Life Sciences
0 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Aveanna Healthcare
0 Very Positive mention(s)
3 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Caris Life Sciences currently has a consensus price target of $27.56, indicating a potential upside of 53.34%. Aveanna Healthcare has a consensus price target of $10.50, indicating a potential upside of 48.10%. Given Caris Life Sciences' higher probable upside, analysts plainly believe Caris Life Sciences is more favorable than Aveanna Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Caris Life Sciences
1 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.45
Aveanna Healthcare
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.67

Summary

Aveanna Healthcare beats Caris Life Sciences on 8 of the 14 factors compared between the two stocks.

How does Aveanna Healthcare compare to Billiontoone?

Aveanna Healthcare (NASDAQ:AVAH) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, analyst recommendations, risk, valuation, institutional ownership, earnings and media sentiment.

88.0% of Aveanna Healthcare shares are held by institutional investors. 5.3% of Aveanna Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Aveanna Healthcare has higher revenue and earnings than Billiontoone. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aveanna Healthcare$2.43B0.63$225.03M$1.186.01
Billiontoone$305.11M15.24$7.45M$0.55183.85

Aveanna Healthcare currently has a consensus target price of $10.50, indicating a potential upside of 48.10%. Billiontoone has a consensus target price of $125.29, indicating a potential upside of 23.90%. Given Aveanna Healthcare's stronger consensus rating and higher possible upside, research analysts plainly believe Aveanna Healthcare is more favorable than Billiontoone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aveanna Healthcare
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.67
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50

Aveanna Healthcare has a net margin of 10.37% compared to Billiontoone's net margin of 0.00%. Aveanna Healthcare's return on equity of 124.68% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
Aveanna Healthcare10.37% 124.68% 7.07%
Billiontoone N/A N/A N/A

In the previous week, Billiontoone had 5 more articles in the media than Aveanna Healthcare. MarketBeat recorded 9 mentions for Billiontoone and 4 mentions for Aveanna Healthcare. Aveanna Healthcare's average media sentiment score of 0.59 beat Billiontoone's score of -0.55 indicating that Aveanna Healthcare is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aveanna Healthcare
0 Very Positive mention(s)
3 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Billiontoone
1 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Negative

Summary

Aveanna Healthcare beats Billiontoone on 12 of the 14 factors compared between the two stocks.

How does Aveanna Healthcare compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and Aveanna Healthcare (NASDAQ:AVAH) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, media sentiment, risk, analyst recommendations, institutional ownership and dividends.

Sotera Health currently has a consensus price target of $20.29, suggesting a potential upside of 25.30%. Aveanna Healthcare has a consensus price target of $10.50, suggesting a potential upside of 48.10%. Given Aveanna Healthcare's higher possible upside, analysts clearly believe Aveanna Healthcare is more favorable than Sotera Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sotera Health
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73
Aveanna Healthcare
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.67

Aveanna Healthcare has higher revenue and earnings than Sotera Health. Aveanna Healthcare is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sotera Health$1.16B3.97$77.94M$0.4139.49
Aveanna Healthcare$2.43B0.63$225.03M$1.186.01

91.0% of Sotera Health shares are held by institutional investors. Comparatively, 88.0% of Aveanna Healthcare shares are held by institutional investors. 15.4% of Sotera Health shares are held by insiders. Comparatively, 5.3% of Aveanna Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Sotera Health has a beta of 1.79, meaning that its stock price is 79% more volatile than the broader market. Comparatively, Aveanna Healthcare has a beta of 1.93, meaning that its stock price is 93% more volatile than the broader market.

Aveanna Healthcare has a net margin of 10.37% compared to Sotera Health's net margin of 9.91%. Aveanna Healthcare's return on equity of 124.68% beat Sotera Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Sotera Health9.91% 39.73% 7.05%
Aveanna Healthcare 10.37%124.68%7.07%

In the previous week, Aveanna Healthcare had 1 more articles in the media than Sotera Health. MarketBeat recorded 4 mentions for Aveanna Healthcare and 3 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.16 beat Aveanna Healthcare's score of 0.59 indicating that Sotera Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sotera Health
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Aveanna Healthcare
0 Very Positive mention(s)
3 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Aveanna Healthcare beats Sotera Health on 10 of the 17 factors compared between the two stocks.

How does Aveanna Healthcare compare to RadNet?

Aveanna Healthcare (NASDAQ:AVAH) and RadNet (NASDAQ:RDNT) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, media sentiment, dividends, analyst recommendations, valuation, risk and profitability.

88.0% of Aveanna Healthcare shares are owned by institutional investors. Comparatively, 77.9% of RadNet shares are owned by institutional investors. 5.3% of Aveanna Healthcare shares are owned by insiders. Comparatively, 5.6% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Aveanna Healthcare has a net margin of 10.37% compared to RadNet's net margin of -0.66%. Aveanna Healthcare's return on equity of 124.68% beat RadNet's return on equity.

Company Net Margins Return on Equity Return on Assets
Aveanna Healthcare10.37% 124.68% 7.07%
RadNet -0.66%2.77%0.97%

Aveanna Healthcare has a beta of 1.93, indicating that its stock price is 93% more volatile than the broader market. Comparatively, RadNet has a beta of 1.41, indicating that its stock price is 41% more volatile than the broader market.

In the previous week, RadNet had 3 more articles in the media than Aveanna Healthcare. MarketBeat recorded 7 mentions for RadNet and 4 mentions for Aveanna Healthcare. RadNet's average media sentiment score of 0.72 beat Aveanna Healthcare's score of 0.59 indicating that RadNet is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aveanna Healthcare
0 Very Positive mention(s)
3 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
RadNet
2 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Aveanna Healthcare currently has a consensus target price of $10.50, suggesting a potential upside of 48.10%. RadNet has a consensus target price of $87.43, suggesting a potential upside of 54.17%. Given RadNet's stronger consensus rating and higher probable upside, analysts plainly believe RadNet is more favorable than Aveanna Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aveanna Healthcare
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.67
RadNet
1 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
2.90

Aveanna Healthcare has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aveanna Healthcare$2.43B0.63$225.03M$1.186.01
RadNet$2.04B2.19-$18.65M-$0.18N/A

Summary

Aveanna Healthcare beats RadNet on 9 of the 16 factors compared between the two stocks.

Get Aveanna Healthcare News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVAH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVAH vs. The Competition

Export
MetricAveanna HealthcareMED IndustryMedical SectorNASDAQ Exchange
Market Cap$1.54B$5.70B$6.74B$12.04B
Dividend YieldN/A1.53%2.67%5.61%
P/E Ratio11.6235.0624.0224.44
Price / Sales0.6322.17510.83109.87
Price / Cash10.2816.6944.0155.64
Price / Book7.623.1210.656.78
Net Income$225.03M$218.81M$3.57B$338.00M
7 Day Performance6.14%1.92%0.83%2.68%
1 Month Performance4.73%0.72%0.09%2.16%
1 Year Performance44.40%14.98%25.18%30.48%

Aveanna Healthcare Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVAH
Aveanna Healthcare
4.7854 of 5 stars		$7.09
+1.3%		$10.50
+48.1%		+39.6%$1.54B$2.43B11.6235,500
PACS
PACS Group
3.7503 of 5 stars		$36.82
+3.6%		$48.00
+30.4%		+243.0%$5.80B$5.43B22.5647,455
CAI
Caris Life Sciences
4.4296 of 5 stars		$16.53
+0.5%		$27.56
+66.7%		N/A$4.73B$812.03MN/A1,846
BLLN
Billiontoone
3.7334 of 5 stars		$94.34
+3.5%		$125.29
+32.8%		N/A$4.55B$354.54M164.81620
SHC
Sotera Health
3.7517 of 5 stars		$15.03
-3.3%		$20.33
+35.3%		+37.8%$4.43B$1.19B37.203,000

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:AVAH) was last updated on 6/13/2026 by MarketBeat.com Staff.
From Our Partners
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
One hidden supplier shipped 5 billion parts to SpaceX
Most investors are focused on the historic $1.75 trillion SpaceX IPO expected around June 30. But there's a le...
Weiss Ratings | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
I paid $5,000 to hear Elon say this
One investor paid $5,000 to be in a private room with Elon Musk in Los Angeles - and what he heard confirmed a...
InvestorPlace | Sponsoredtc pixel